About Cerveau Technologies
Cerveau Technologies is a company based in Boston (United States) founded in 2015 was acquired by Lantheus in February 2023. Cerveau Technologies offers products and services including MK-6240. Cerveau Technologies operates in a competitive market with competitors including Blue Matter Consulting, MCRA, PharmAla Biotech, CHDR and CATALIS, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerveau Technologies
Cerveau Technologies offers a comprehensive portfolio of products and services, including MK-6240.
Investigational tracer for detecting tau tangles in Alzheimer's disease.
People of Cerveau Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Cerveau Technologies
Detailed funding history for Cerveau Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cerveau Technologies
Cerveau Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of diagnostic imaging agents and targeted therapeutics
|
Locked | Locked | Locked |
Investor details for Cerveau Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cerveau Technologies
Investment portfolio details for Cerveau Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cerveau Technologies
Detailed financials for Cerveau Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cerveau Technologies Comparisons
Peer comparison for Cerveau Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cerveau Technologies
Cerveau Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Matter Consulting, MCRA, PharmAla Biotech, CHDR and CATALIS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of consulting services focused for clinical drug development
|
|
| Locked | Locked | Locked |
Provider of regulatory, quality assurance and market access services to biopharma sector
|
|
| Locked | Locked | Locked |
Biomanufacturing, regulatory, and financial services are provided by PharmAla Biotech.
|
|
| Locked | Locked | Locked |
Early-stage clinical drug research consulting services are provided.
|
|
| Locked | Locked | Locked |
Consulting services for clinical drug development and trials are provided.
|
|
| Locked | Locked | Locked |
Specialized consulting in clinical biometrics and regulatory affairs is provided.
|
Detailed competitors of Cerveau Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cerveau Technologies
Complete news archive for Cerveau Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerveau Technologies
Cerveau Technologies was founded in 2015.
Cerveau Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Founded in 2015 in Boston, United States, Cerveau Technologies is involved in research on early-stage imaging agents, radiopharmaceuticals, and neurodegenerative diseases. Global commercial strategies and student exchange programs are offered to support clinical development. Agreements with universities and industries, including Siemens Healthineers, Merck, Biogen, McGill University, and Austin Health, are upheld for publishable data generation and manufacturing of positron emission tomography tools.
Cerveau Technologies's top competitors include S-Cubed, Blue Matter Consulting and PharmAla Biotech.
Cerveau Technologies offers MK-6240.
Cerveau Technologies has 1 investor. Key investors include Lantheus.